Conclusion
Human IL-10 DC-induced iTreg facilitate allergen-specific and
cross-reactive tolerance. Therefore, they are potential candidates for
regulatory cell therapy in allergic and autoimmune diseases.
Key words
- type I allergy
- Bet v 1.01
- tolerogenic IL-10 DC
- regulatory T cells
- cross-reactive tolerance